Targeting the JAK/STAT3 pathway with ruxolitinib for RDEB-cSCC therapy

被引：0
|
作者：
Jackow, J. [1 ]
Hayashi, R. [1 ]
Owens, D. [1 ]
Perez-Lorenzo, R. [1 ]
Hansen, C. [1 ]
DeLorenzo, D. [1 ]
Guo, Z. [1 ]
Christiano, A. [1 ]
机构：
[1] Columbia Univ, Dermatol, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 09期
关键词：
D O I：
10.1016/j.jid.2019.07.525
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
475
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [41] The potential of JAK/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19
    Bagca, Bakiye Goker
    Avci, Cigir Biray
    CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 54 : 51 - 61
  • [42] A new modality for immunosuppression: targeting the JAK/STAT pathway
    John J. O'Shea
    Marko Pesu
    Dominic C. Borie
    Paul S. Changelian
    Nature Reviews Drug Discovery, 2004, 3 : 555 - 564
  • [43] Targeting JAK/STAT pathway in Takayasu's arteritis
    Regnier, Paul
    Le Joncour, Alexandre
    Maciejewski-Duval, Anna
    Desbois, Anne-Claire
    Comarmond, Cloe
    Rosenzwajg, Michelle
    Klatzmann, David
    Cacoub, Patrice
    Saadoun, David
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (07) : 951 - 959
  • [44] A new modality for immunosuppression: Targeting the JAK/STAT pathway
    O'Shea, JJ
    Pesu, M
    Borie, DC
    Changelian, PS
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (07) : 555 - 564
  • [45] TARGETING JAK/STAT PATHWAY IN TAKAYASU'S ARTERITIS
    Regnier, P.
    Le Joncour, A.
    Maciejewski-Duval, A.
    Desbois, A. C.
    Comarmond, C.
    Rosenzwajg, M.
    Klatzmann, D.
    Cacoub, P.
    Saadoun, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1062 - 1062
  • [46] Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity
    Shaker, Mohamed E.
    Hazem, Sara H.
    Ashamallah, Sylvia A.
    FOOD AND CHEMICAL TOXICOLOGY, 2016, 96 : 290 - 301
  • [47] Targeting the JAK/STAT Signaling Pathway for Breast Cancer
    Shao, Fei
    Pang, Xiaonan
    Baeg, Gyeong Hun
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5137 - 5151
  • [48] Targeting transcription factor STAT3 for cancer prevention and therapy
    Chai, Edna Zhi Pei
    Shanmugam, Muthu K.
    Arfuso, Frank
    Dharmarajan, Arunasalam
    Wang, Chao
    Kumar, Alan Prem
    Samy, Ramar Perumal
    Lim, Lina H. K.
    Wang, Lingzhi
    Goh, Boon Cher
    Ahn, Kwang Seok
    Hui, Kam Man
    Sethi, Gautam
    PHARMACOLOGY & THERAPEUTICS, 2016, 162 : 86 - 97
  • [49] Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
    Malemud, Charles Jay
    Pearlman, Eric
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (03) : 201 - 221
  • [50] Targeting the JAK/STAT pathway in cancer with curcumin derivatives
    Fuchs, James R.
    Schwartz, Eric B.
    Abdelhamid, Dalia
    Etter, Jonathan P.
    Li, Chenglong
    Li, Pui-Kai
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
12345